Autism information, without the 12-year wait.
Plain-language resources for autistic people, parents, and carers — built to close the gap between what researchers know and what families can actually use.
That's how long it typically takes for new findings, diagnostic updates, and support approaches to reach the people who need them. This site exists to shorten it.
Sourced from Autistic Self Advocacy Network, Reframing Autism, AASPIRE, CommunicationFIRST, and current peer-reviewed research from BMJ, Autism, Autism in Adulthood, Nature Medicine, and the CDC ADDM Network. Every factual claim on this site links to its source.
What is autism?
A clear, respectful overview. Written in plain language, without jargon, and using terminology preferred by autistic communities.
Autism is a lifelong way the brain develops and works. Autistic people tend to think, communicate, move, and experience the senses differently from non-autistic people. It shapes how someone connects with others, processes information, and navigates the world — and those differences show up in a huge variety of ways from one person to the next.
Common traits
Most autistic people share some broad traits, though the mix is different for everyone. These often include differences in social communication (like reading unspoken cues or small talk), a preference for predictability and routine, deep focused interests, and sensory experiences that feel sharper, duller, or simply different to other people's.
Many autistic people also stim — repetitive movements or sounds that help regulate emotion and sensory input. Traits can look very different in adults, in women and non-binary people, and across cultures, which is part of why so many people are identified later in life.
What it isn't
Autism is not an illness, and it doesn't need curing — it's a difference, not a disease. It isn't caused by vaccines, parenting, or screen time; the evidence on that is clear. It also isn't a single look.
The old split between "high-functioning" and "low-functioning" has been set aside by most autistic-led organisations, including the Autistic Self Advocacy Network and Reframing Autism, because it flattens real support needs and ignores how much those needs shift with context, energy, and environment. Talking about low, moderate, or high support needs is more honest and more useful.
Tap a card. Get the answer.
A flickable, tap-to-flip guide through the questions parents and newly-diagnosed adults ask most. Keyboard friendly: press Enter or Space on any card. Prefer to scan? Use the toggle below.
Gender, identification, and what the numbers really show
For decades, the textbook line has been that autism is roughly four times more common in boys than girls. A growing body of longitudinal research is quietly challenging that — the strongest evidence yet coming from a 2026 Swedish cohort study. The short version: girls and women may not be less autistic; they were being missed.
Different healthcare systems produce different numbers. Swedish registries capture late-diagnosed adults better than many other systems do, so ratios in the US, UK, and Australia may still look closer to 3:1 or 4:1 for some years yet. The direction of travel is clear; the exact ratio in your country may lag.
The picture is shifting fast
A February 2026 BMJ study followed 2.7 million Swedish people born between 1985 and 2022. Boys were diagnosed more often in childhood, but girls caught up during adolescence and adulthood — by age 20 the ratio was almost even. The researchers concluded that the historical 4:1 figure largely reflects late diagnosis in girls and women, not a real difference in how often autism occurs. It's the strongest evidence to date, but it's one study in one country, and replication in other healthcare systems is still catching up.
An earlier US cohort study (Burrows et al., 2022) used direct assessments of young children rather than existing diagnoses and found a 1:1 gender ratio for children showing "high concern" for autism traits. Both findings point the same direction.
Why women get missed
Autism research, diagnostic tools, and clinical training were built on mostly-male samples from the 1940s onward. The result: the "classic" presentation clinicians learned to recognise is a male-presenting one. Many autistic girls and women mask more — learn to mimic social scripts, hide stims in public, force eye contact — which looks like "not autism" to a clinician using older criteria.
One consequence: late-diagnosed women are routinely misdiagnosed first. Research on late-diagnosed women finds they are often diagnosed with anxiety, depression, borderline personality disorder, or eating disorders before autism is recognised — sometimes decades before. Around 26% of late-diagnosed women have co-occurring conditions, compared with 13% of late-diagnosed men.
What this means in practice
If you're a woman, non-binary person, or assigned-female-at-birth person who has always wondered whether you might be autistic — the statistical base rate is closer to what you see in autistic men than it is to the 1-in-4 figure older materials suggest. A late diagnosis is a valid diagnosis, and for many people it reframes a lifetime of being told they were "too sensitive," "too intense," or just "a bit odd."
For clinicians and parents: a child who doesn't present classically but who masks, has intense focused interests in socially-acceptable topics, or shows signs like selective mutism, chronic exhaustion from school, or sudden collapse during adolescence deserves an autism assessment — not just a mental health one.
Just diagnosed. What now?
Written for parents in the first days and weeks after a child's diagnosis — and, further down, for autistic kids reading this themselves. The single most important thing: your child is exactly the same person they were the day before the diagnosis.
The first week
Feel what you feel. Read something written by autistic people. Don't decide anything big yet.
The first month
Learn your child's sensory profile and regulation tools. Look into NDIS access (or Thriving Kids from Oct 2026).
The first year
Build a small, honest team — GP, one or two therapists, a school that adapts. Choose therapies carefully.
These are signposts, not a checklist. Every family moves at its own pace; there is no "developmental window" you'll miss by going slowly.
The first week
Give yourself permission to feel whatever you feel. Relief, grief, confusion, and love can all turn up in the same hour, and none of them mean you're doing this wrong. You don't need to make any big decisions this week.
Two useful things to do early: read something written by autistic people rather than just about them, and hold off on sharing the diagnosis widely until your child (if they're old enough) has a say in who knows. Reframing Autism is an Australian autistic-led organisation with excellent free resources for parents who have just had this news.
The first month
Start learning what your child's autism actually looks like day to day — their sensory profile, what tips them into a meltdown, what they use to regulate (stimming, a special interest, quiet time), and when they mask. Meltdowns and shutdowns aren't misbehaviour; they're a signal that something was too much.
If you're in Australia and your child is under nine, this is also when you'd normally explore NDIS access. From 1 October 2026, children aged 8 and under with low-to-moderate support needs will be directed to the new state-based Thriving Kids program instead. Ask your paediatrician or early childhood partner which pathway fits your child, and what a functional capacity assessment would involve.
The first year
Build a small, honest team — a GP or paediatrician who listens, one or two therapists your child actually likes, and a school that's willing to adapt rather than one demanding your child adapt. Therapies are tools, not obligations; your child doesn't need every therapy that exists, and there is no "developmental window" that closes if you don't book the lot this term.
On therapy choices: occupational therapy for sensory needs and speech therapy (including AAC for non-speaking or part-time speaking kids) are widely supported by the autistic community. Applied Behaviour Analysis (ABA) is contested. Many autistic adults who went through it as children describe lasting harm, and autistic-led organisations recommend strengths-based, neurodiversity-affirming alternatives. It's worth reading ASAN's position before deciding.
Telling your child
Most autistic adults say the same thing in hindsight: they wish they'd been told earlier, more clearly, and without shame. How you frame it matters more than the exact age. The Child Mind Institute's guidance is a good start: explain autism as a difference in how their brain works, name the real strengths alongside the harder parts, and make clear that none of it is their fault.
For young children (around 5–8), keep it concrete: "Your brain is wired to notice sounds other people miss, and that's why the school hall feels so loud." For tweens (9–12), invite their questions and read an autistic-authored kids' book together. For teens, be honest, go slowly, and be ready for anger, grief, or relief — often all three.
Looking after yourself
Between a quarter and a half of parents of autistic children discover they're autistic themselves once they start learning what autism actually looks like. If reading this is making something click, that's worth paying attention to — not dismissing. Autistic parents often parent autistic kids brilliantly.
Parent burnout is real and under-recognised. Keeping your own nervous system in reach of "okay" is part of the job, not a selfish distraction from it.
How autism is classified globally
Diagnostic criteria differ by country and system. Here's a clear comparison — because a diagnosis in one country may be framed differently in another.
DSM-5-TR
Published by the American Psychiatric Association in 2022, the DSM-5-TR is the main diagnostic manual used in the US and widely referenced elsewhere. It folds older labels like Asperger's and PDD-NOS into a single diagnosis: Autism Spectrum Disorder. Diagnosis requires persistent differences in social communication and restricted or repetitive behaviours, present from early development. Severity is rated across three levels of support need.
ICD-11
The WHO's ICD-11 came into full effect in 2022 and is used by health systems across most of the world. Autism sits under code 6A02, with sub-codes noting whether intellectual development or functional language are affected. Like the DSM, it replaces older sub-types. The ICD is the backbone of most non-US public health reporting and insurance coding.
NDIS & clinical pathway
Diagnosis usually comes through a paediatrician, psychiatrist, or multi-disciplinary team using DSM-5-TR criteria. Funding flows through the National Disability Insurance Scheme (NDIS). From 1 October 2026, a new program called Thriving Kids is scheduled to begin rolling out for children aged 8 and under with low-to-moderate support needs, moving that group from the NDIS to state-based mainstream supports by 2028. Rollout details, eligibility thresholds, and timelines are still being finalised — check the Department of Health page for the current status before making plans. Children with higher support needs stay on the NDIS.
NICE guidelines
NICE guidelines say an autism assessment should start within three months of referral — in practice, NHS waits are far longer. Diagnosis is done by a specialist autism team covering either children or adults. England's national autism strategy 2021–2026 set goals around shorter waits and better post-diagnostic support. Scotland, Wales, and Northern Ireland each run their own pathways.
National variation
There's no single European pathway. Most countries use ICD-11, but how and where you get assessed — and what support follows — varies widely. Some countries (the Nordics, the Netherlands) have relatively joined-up public systems; others rely heavily on private clinics or NGOs. Adult diagnosis is patchy almost everywhere, and language around autism varies too, with identity-first language more established in some countries than others.
Emerging frameworks
Access and awareness differ sharply across the region. Many countries use ICD-11 but have few specialists, long waits, and little publicly funded support — families often rely on NGOs, schools, and word of mouth. Cultural stigma still affects diagnosis rates. Recent large genetic studies, including a 2026 Mount Sinai study in Nature Medicine, confirm autism's genetic architecture is consistent across ancestries — which matters for future equity in diagnosis.
Advances in support & recovery
A note on language: we don't treat autism as something to recover from. We do cover recovery from autistic burnout, and genuine advances in supports that make day-to-day life better. Here's what's changing.
Neurodiversity-affirming therapy is becoming the default
The shift away from therapies that try to make autistic people "look less autistic" is the biggest change in the field right now. A 2025 review in Counselling and Psychotherapy Research argued for moving away from approaches focused on masking autistic traits and toward supports that target distress and co-occurring anxiety, depression, and trauma instead.
Occupational therapy, speech therapy, and mental health care are all moving in the same direction: adapt the environment, don't try to re-engineer the person. The 2025 SAGE scoping review on neurodiversity-affirming care found clear practical shifts in how clinicians and educators are being trained.
Autistic burnout now has real evidence behind it
Autistic burnout — long-term exhaustion, loss of skills, and reduced tolerance to everyday stimulus — was barely in the research literature until Dora Raymaker and the AASPIRE team named and defined it in 2020. By 2025, researchers were reviewing dozens of studies on it.
Recovery themes that keep coming up: having language for what's happening, unmasking in safe spaces, radical rest (not "reward" rest), sensory relief, cutting non-essential demands, and community with other autistic people. Recovery is usually slow, measured in months rather than weeks. The National Autistic Society has a plain-language overview drawn from Raymaker's work.
Better pathways for adults and late-diagnosed people
Diagnostic tools are slowly catching up with how autism actually presents in women, non-binary people, and adults who learned to mask. New 2025 collaborative assessment frameworks push clinicians to include the person being assessed as a partner in the process, with strengths-based language and an honest conversation about what the diagnosis will and won't change day to day.
Medication: supporting, not curing
There are still no medications approved for autism's core traits, and the research community has largely stopped looking for one. A 2026 review in Neurotherapeutics describes the current focus as biologically informed, stratified treatment for co-occurring conditions — anxiety, sleep, epilepsy, GI issues — where medication often does help. Claims of "cures" (chelation, stem-cell infusions, restrictive diets marketed as treatments) are not supported by the evidence and carry real risks.
On contested treatments and causes
If you're a parent with a newly diagnosed child, your social feed has almost certainly shown you someone promising to cure, reverse, or recover your child from autism. This section exists because those claims deserve to be addressed seriously — not dismissed, not endorsed. Here's what each view says, what the evidence actually shows, and where to look further.
The principle underneath this section. Parents who look into alternative autism treatments are almost always doing it out of love, fear, and a sense that the system hasn't given them enough. Those feelings are real and they deserve respect. This page tries to be honest about what the evidence shows without dismissing the worry underneath.
You'll notice the structure: each claim is stated in the words its proponents use, then weighed against what peer-reviewed evidence and autistic-led organisations say. If something on this page sits uncomfortably, feel free to get in touch — the contact box at the bottom has a way through.
-
The claim
Vaccines — particularly the MMR vaccine — cause autism.
What the view says
Proponents argue that autism rates rose as childhood vaccination schedules expanded, that some parents observed regression shortly after vaccination, and that the mercury-based preservative thimerosal (removed from most childhood vaccines by 2001) or aluminium adjuvants trigger an immune response causing autism. The theory originated with a 1998 paper in The Lancet by gastroenterologist Andrew Wakefield.
What the evidence shows
Wakefield's original paper was retracted by The Lancet in 2010 after a BMJ investigation found it was fraudulent — the medical histories of the 12 children had been deliberately altered, and Wakefield had undisclosed financial conflicts, including planned sales of a competing vaccine product. He was struck off the UK medical register in 2010. The High Court later upheld the fraud findings.
Since 1998, more than a dozen large studies — one covering over 650,000 Danish children, another covering over 1 million children across multiple countries — have looked for a link between vaccines (MMR, thimerosal, aluminium, the full schedule) and autism. None has found one. The signs of autism typically emerge at the same age children happen to receive routine vaccines, which creates an apparent correlation that disappears under proper study design.
Vaccine rate drops driven by this claim have caused documented deaths — children have died in measles outbreaks linked to the vaccine scare in the UK, US, Europe, and Samoa.
A note for parents who saw something change. A lot of parents remember a vaccine and then a regression, and feel they've been dismissed when they've raised it. That experience is real. Autistic regression typically becomes visible between 12 and 24 months — which is also when MMR and several other vaccines are scheduled. When two things happen in the same month, the brain links them, and that's not irrational; it's how human pattern-recognition works. The research has specifically tested whether the vaccine caused the regression or the regression was always going to emerge then, and the answer, repeatedly, is the second one. None of that means you imagined what you saw. It means what you saw wasn't caused by the shot. If a clinician has ever made you feel foolish for asking, that was their failure, not yours.
Sources: Deer, BMJ, 2011 (the fraud investigation) · Hviid et al., Annals of Internal Medicine, 2019 (Danish 650,000-child study) · CDC summary · Cochrane MMR review -
Reading a study
Six questions to ask before a study changes your mind
Studies get shared on social media with headlines that run well ahead of what the paper actually shows. That's true of pro-vaccine coverage and anti-vaccine coverage alike. If you're trying to form a view from a paper someone sent you, these six questions will get you most of the way there. You don't need a stats degree — you just need to check the basics.
- Is it actually published in a peer-reviewed journal? "Peer review" means other scientists in the field have read the paper and raised objections the authors had to answer before publication. A PDF circulating online, a manuscript entered into a Senate record, or a document uploaded to ResearchGate is not peer-reviewed. Platforms like ResearchGate, Substack, and preprint servers (bioRxiv, medRxiv) host unreviewed work. Quick check: search the journal name + the paper title on Google Scholar. If it's not there with a DOI link, it's not been through peer review.
- How big is each group, and how long were they followed? A study comparing 2,000 children over 15 months against 16,000 children over three years is not really comparing the same thing. Conditions like autism, ADHD, and learning disabilities typically aren't diagnosed until age four or later. If one group is followed too briefly, those diagnoses can't be detected — it looks like they don't exist. Quick check: look for the median follow-up time, reported in each group separately. If one is half the other, the shorter group will appear healthier regardless of what vaccines do.
- Are the groups actually comparable? Families who decline all vaccines are demographically unusual. They often have different education, income, home birth rates, breastfeeding patterns, dietary choices, and healthcare use than average families. If a study doesn't adjust for these, apparent "vaccine effects" might really be "differences in family circumstances." Quick check: look for a baseline table comparing the two groups. If they differ on race, prematurity, birth weight, or socioeconomic status — and those aren't adjusted for — the comparison is weak.
- How often did each group see a doctor? You can only be diagnosed with a condition you bring to a clinic. Children who attend well-visits get screened. Children who don't, aren't. If one group has three times the medical encounters of the other, the first group will always show more diagnoses — even if the underlying health is identical. This is called ascertainment bias. Quick check: does the paper report average number of medical encounters per child? If there's a big gap, the result may reflect who was seen, not who was sick.
- What did the authors actually find — not the headline? Study summaries get rewritten by advocates. Look at the actual results tables. A study might show a headline "vaccines linked to chronic illness" while, inside the same paper, finding no statistically significant link to autism, cancer, or seizure disorders specifically. Both things can be true of the same paper, and both deserve to be mentioned. Quick check: look for the word "significant" or p-values. A result with p > 0.05 or a confidence interval that crosses 1.0 is not a statistically reliable finding, even if the numbers look dramatic.
- What does the wider evidence base say? A single study almost never overturns an established finding. Medicine moves on the weight of multiple studies, systematic reviews, and replication. One paper showing an unexpected result is a prompt for more research — not yet a reason to change practice. Look for systematic reviews (Cochrane, BMJ Evidence-Based Medicine) or meta-analyses for the fuller picture. Quick check: has this finding been replicated by independent teams? If it's only one group, one dataset, one paper — sit with it but don't hang a decision on it yet.
None of this makes you a statistician, and none of it means you should dismiss studies that challenge current thinking. Real challenges to accepted science do happen. They just tend to come through better studies, not louder ones. If you'd like help reading a specific paper, get in touch.
-
The claim
Autism is actually a neuroimmune disease — chronic viral infection and brain inflammation — treatable with antivirals and immune modulators.
What the view says
This is the position of Dr Michael Goldberg in The Myth of Autism (2011) and associated writings. Proponents argue that NeuroSPECT brain scans show reduced perfusion ("holes") in autistic children's brains, that these patterns overlap with chronic fatigue syndrome, and that children can improve significantly with the "Goldberg Approach" — a protocol of antivirals, antifungals, immune modulators, dietary change, and supplements.
What the evidence shows
Dr Goldberg is a qualified paediatrician and his clinical observations are his own. The question is whether his interpretation is supported by peer-reviewed evidence. The answer is: not yet, and not for over thirty years.
The NeuroSPECT findings cited in the book (developed with Ismael Mena at Harbor-UCLA) have not been independently replicated as a reliable diagnostic tool for autism. No randomised controlled trial of the Goldberg Approach has been published. No major paediatric neurology body — the American Academy of Pediatrics, Royal Australian College of Physicians, NICE, or equivalent — recognises autism as a neuroimmune disease or recommends this protocol.
Autistic brains do show real neurological differences — not damage, but genuine developmental and functional differences that are part of who autistic people are. Many autistic people also experience dysregulated stress responses in environments not built for them. That's covered elsewhere on this site. The leap from those real differences to "autism is an inflammatory disease curable with off-label medication" is not supported by current evidence, and the supplements and off-label antivirals involved carry real risks when given to children without clear indication.
Sources: American Academy of Pediatrics autism resources · Reframing Autism's position on "cure" frameworks · Goldberg & Goldberg, The Myth of Autism, Skyhorse, 2011 (primary source for the claim) -
The claim
Chelation therapy removes heavy metals (especially mercury) from the body and reverses autism.
What the view says
Proponents — notably the "Defeat Autism Now!" (DAN!) movement in the 2000s — argued that mercury from vaccines or environmental sources accumulates in autistic children's bodies and causes the condition. Chelation uses chemicals (EDTA, DMSA, DMPS) that bind to heavy metals so they can be excreted. The promise: remove the metals, reverse the autism.
What the evidence shows
No peer-reviewed study has shown that autistic people have abnormal heavy metal levels compared to non-autistic peers. A 2015 Cochrane review found no evidence that chelation helps autistic children. The theory that links it to vaccines has been thoroughly debunked (see the vaccines entry above).
Chelation is not safe when misused. A 5-year-old autistic child, Abubakar Nadama, died of cardiac arrest during chelation treatment in Pennsylvania in 2005 after being given the wrong form of EDTA. The NIMH suspended a planned chelation trial for ethical reasons. The FDA has issued consumer warnings. Documented side effects include kidney failure, dangerously low calcium, dehydration, and death.
Chelation is legitimate medicine for actual heavy metal poisoning — that's what it was designed for. It is not a treatment for autism, and administering it to a child without genuine poisoning is dangerous.
-
The claim
MMS (Miracle Mineral Solution / chlorine dioxide) cures autism by killing parasites and pathogens.
What the view says
Proponents — most prominently former real-estate agent Kerri Rivera, building on the work of Jim Humble — argue that autism is caused by parasites, pathogens, and heavy metals, and that a chlorine dioxide solution taken orally or as an enema eliminates them. Rivera's book Healing the Symptoms Known as Autism claimed to have taken children "off the spectrum" using this protocol.
What the evidence shows
There is no scientific evidence that parasites cause autism. MMS is chlorine dioxide — industrial bleach. The FDA has repeatedly warned that ingesting it is dangerous and potentially fatal. Documented harms include severe vomiting, diarrhoea, dehydration, liver failure, kidney failure, and death. US poison control centres have handled thousands of MMS-related cases, with documented deaths.
Kerri Rivera is a former real-estate agent, not a doctor. She was legally barred from promoting MMS in Illinois in 2015 after the state Attorney General found her claims were unsubstantiated. Her book was removed from Amazon. The approach has been investigated and condemned by the FDA, FBI, and equivalents in multiple countries.
This is the one entry on this page where the framing is not "evidence doesn't support this" but "this causes direct, documented harm to children." If you know a family giving a child MMS, they need help — getting in touch with a paediatrician or child protection service is appropriate.
-
The claim
The GAPS diet (or gluten-free / casein-free / specific carbohydrate diet) heals the gut and reverses autism.
What the view says
Proponents — particularly Dr Natasha Campbell-McBride — argue that autism stems from "gut and psychology syndrome" (GAPS): leaky gut, dysbiosis, and food toxins that damage the brain. The GAPS protocol involves an elimination diet, bone broths, fermented foods, and extensive supplements. Gluten-free/casein-free (GFCF) diets take a narrower approach, removing wheat and dairy.
What the evidence shows
Many autistic children do have gastrointestinal issues — that's well established. Treating those GI issues can genuinely improve quality of life. The jump from "some autistic children have GI problems" to "diet reverses autism" is not supported by current evidence.
Randomised controlled trials of gluten-free/casein-free diets for autism have found no significant effect on core autism traits. A 2017 Cochrane review concluded the evidence base is weak. The GAPS protocol itself has never been evaluated in a peer-reviewed randomised trial.
Restrictive diets carry real risks for children, particularly autistic children, who often already have limited eating preferences. Documented harms include nutritional deficiencies, low bone density, and increased eating-disorder risk during adolescence. If your child has GI symptoms, a paediatric gastroenterologist can investigate; a full GAPS protocol is not necessary.
-
The claim
Stem cell therapy — infused at private clinics abroad — reverses autism.
What the view says
Private clinics, mostly in Mexico, Panama, China, and Ukraine, offer umbilical cord or mesenchymal stem cell infusions marketed to parents of autistic children at costs typically between USD 20,000 and 80,000. Proponents argue stem cells reduce brain inflammation and allow neurological repair.
What the evidence shows
Small preliminary trials (Duke, Sutter Health) have tested cord-blood stem cell infusions for autism. Results have been mixed to negative — some modest short-term changes in some children, but no evidence of durable improvement in autism traits beyond what's seen with placebo.
The FDA has issued warnings about unapproved stem cell products, and multiple deaths and serious infections have been linked to unregulated overseas stem cell tourism. Paying a clinic abroad for a stem cell infusion for autism means paying for an unproven treatment, with no recourse if something goes wrong, and no evidence the treatment works.
Legitimate stem cell research for autism is still in early clinical trial stages. If it turns out to help a subset of autistic people, that information will come through peer-reviewed trials and regulatory approval — not from private clinics advertising on social media.
-
The claim
Leucovorin (folinic acid) is a new autism treatment recently approved by the FDA.
What the view says
Proponents — including HHS Secretary Robert F Kennedy Jr, FDA Commissioner Marty Makary, and researchers Dr Richard Frye and Dr Dan Rossignol — argue that a subset of autistic children have cerebral folate deficiency (CFD), in which antibodies block folate transport into the brain, and that leucovorin treats that deficiency and improves autism-related speech and behaviour.
What the evidence shows
This one needs careful framing because there's real science underneath and also significant overreach.
In September 2025, the FDA initiated fast-tracked approval of leucovorin for Cerebral Folate Deficiency — a real but rare neurological condition. In March 2026, the FDA explicitly stated that there is insufficient evidence to support using leucovorin for autism, and approved it only for CFD, not for autism generally. The American Academy of Pediatrics concurs: there has not been a large phase 3 trial, results vary, and effects can be positive, neutral, or negative depending on the child.
Some autistic children with genuine CFD may benefit from leucovorin. That's different from leucovorin being an autism treatment. Off-label prescribing has increased sharply, and the AAP is urging caution. If your child has CFD (a specific diagnosis, not just an autism diagnosis), leucovorin is worth discussing with a paediatric neurologist. For autism generally, the evidence isn't there yet.
-
The claim
Children can "recover" from autism and lose their diagnosis.
What the view says
Proponents point to studies showing some children who meet autism criteria in early childhood don't meet criteria later — described as "optimal outcome" in research literature, or "recovery" in popular writing. Advocates of various biomedical and intensive behavioural protocols often claim these children "recovered" because of their intervention.
What the evidence shows
The research is real. A small subset of autistic children — estimates range from around 3% to 25% depending on the study and how "recovery" is defined — later test outside autism diagnostic criteria. But two things matter about those findings.
First, "no longer meets diagnostic criteria" is not the same as "is no longer autistic." Longitudinal research suggests many of these children still experience autistic traits, sensory differences, social exhaustion, and higher rates of anxiety — they've learned to mask, not stopped being autistic. That masking itself is increasingly understood as a driver of burnout, mental health problems, and late-in-life collapse.
Second, the "recovery" is not clearly attributable to any specific intervention. Studies controlling for intensive behavioural intervention show modest effects at most. The children described as having "optimal outcomes" often had specific starting profiles (higher cognitive ability, more speech early) — not specific treatments.
The autistic adult community overwhelmingly rejects "recovery" as a goal. Autistic-led organisations argue for support, accommodation, and thriving as autistic people — not for changing children into approximations of non-autistic ones. Many late-diagnosed adults describe childhoods where they "recovered" on the outside while experiencing severe internal distress.
Questions, disagreement, or a specific claim you've encountered?
If you've come across a treatment, book, or practitioner that isn't covered here — or if something on this page doesn't sit right with you — get in touch. I'd rather have a conversation than have you close the tab feeling unheard. Contact me via peterdempsey.com.
Tools that genuinely help
Assistive tech isn't a fix — it's a set of tools that reduce the mismatch between an autistic person and an environment that wasn't built for them. Some are high-tech, some are a $15 pair of earplugs. All of them work best when chosen with the autistic person, not for them.
AAC (augmentative and alternative communication)
For non-speaking, minimally-speaking, or part-time-speaking autistic people. Ranges from low-tech picture boards and PECS through to app-based speech-generating devices like Proloquo2Go, TouchChat, and LAMP Words for Life.
A 2025 systematic review (Dumitru) found AAC meaningfully supports vocabulary, literacy, and independence when used consistently rather than as an isolated intervention. CommunicationFIRST is the leading autistic-led resource in this space.
Noise-cancelling headphones & earplugs
Probably the single most life-changing piece of assistive tech for sensory-sensitive autistic people. Active noise-cancelling headphones (Bose, Sony, AirPods Pro) for full immersion; flat-response earplugs (Loop, Flare, Vibes) for softening sound without muffling speech.
Not a luxury — for many autistic people they're the difference between a tolerable day and sensory shutdown.
Weighted and compression clothing
Weighted blankets, compression vests, tight-fit clothing, and weighted lap pads provide proprioceptive input that many autistic people find calming. Evidence is mixed in formal trials but strong in autistic self-reports.
Worth trying before buying expensive — a snug hoodie or a heavy duvet may do the same job.
Visual and lighting tools
Tinted lenses (Irlen, TheraSpecs), dimmable and warm lighting, blue-light filters, and low-glare screens reduce the sensory load of a typical classroom, office, or home. Flicker-free bulbs matter more than people realise — many autistic people are sensitive to the flicker of fluorescent lights others can't perceive.
Visual schedules & timers
Tools like Time Timer (physical), Tiimo, Routinery, and Todoist visualise the passage of time and break tasks into sequences. Especially useful for transitions, routine changes, and task initiation — three areas many autistic people find hard.
Kids' versions often work well for adults too; don't let the branding put you off.
Task & focus apps
Goblin.tools is an autistic-built, free web toolkit that breaks overwhelming tasks into manageable micro-steps, rewrites emails for tone, estimates how long things will take, and more. Widely recommended by autistic adults; worth bookmarking even if you skip everything else on this list.
Other useful options: Focusmate, Todoist, and Notion templates tailored for ADHD/autism. The goal is external scaffolding — letting the app hold the sequence so your working memory doesn't have to.
Text-first communication
Many autistic people communicate more easily by text than by voice. Signal, Discord, email, and workplace tools like Slack are assistive tech in their own right when they replace phone calls and unstructured face-to-face meetings.
Asking for accommodations like "please email rather than call" isn't being difficult — it's using the mode you communicate best in.
Smart-home tools
Voice assistants, smart lights, automated routines, and reminder systems reduce the cognitive load of running a household. Useful for autistic people who find task-switching, memory, or decision fatigue challenging. Low-stakes starter: a smart plug on a lamp and a daily reminder for medication.
AI-assisted communication
Tools like ChatGPT and Claude are being used by many autistic adults to draft emails, translate neurotypical social scripts, check tone, and rehearse difficult conversations. A 2024 review in Sensors catalogued a fast-growing body of AI-in-AAC research.
Use with some care — AI can reinforce masking if you let it smooth every rough edge. Worth pairing with conversations with actual autistic people about when to mask and when not to.
Paying for this in Australia
Assistive technology is fundable under the NDIS for participants whose plans include it. Categories include communication devices, sensory tools, and sometimes smart-home adaptations. Talk to your support coordinator or plan manager — and get an OT assessment if you need one to justify higher-cost items.
The Thriving Kids program is scheduled to change this landscape for children aged 8 and under with low-to-moderate support needs from 1 October 2026. What that means for AT funding is still being worked out — check the official Department of Health page for the current status, and ask your early childhood partner directly before assuming what's covered.
Books worth your time
A starting shelf of current, well-regarded autism books — grouped by what you might be looking for. Autistic authors first, because lived experience matters.
Unmasking Autism
Devon Price, 2022. Blends research and personal writing to explore how autistic people mask, what it costs, and what unmasking can look like. Widely recommended as a first book for late-diagnosed adults.
Late Bloomer
Clem Bastow, 2021. A Melbourne memoir about being diagnosed at 36 — funny, sharp, and quietly angry in the right places. Probably the best starting point if you're an Australian adult wondering about yourself.
Different, Not Less
Chloé Hayden, 2022. Part memoir, part practical guide from an autistic and ADHD advocate. Good for younger readers, families, and anyone who needs the "you're not broken" message in clear terms.
But Everyone Feels This Way
Paige Layle, 2024. A memoir about getting diagnosed at 15 and untangling what the diagnosis actually meant. Honest about the hard parts without tipping into tragedy.
We're Not Broken
Eric Garcia, 2021. A journalist's look at autistic life in the US — education, work, policing, healthcare — grounded in interviews with autistic people rather than parents or clinicians.
Self-Care for Autistic People
Dr Megan Anna Neff, 2024. Practical, gentle workbook-style guide from an autistic psychologist. Particularly useful for burnout, sensory regulation, and interoception.
Uniquely Human (updated edition)
Barry Prizant, updated 2022. A clinician's book that genuinely listens. Widely respected by autistic adults, which is rarer than it should be in this genre. A good gift for a grandparent or teacher.
Sincerely, Your Autistic Child
Emily Paige Ballou, Sharon daVanport and Morénike Giwa Onaiwu (eds.), 2021. Essays by autistic adults writing to the parents of autistic children. The single best book to hand to a parent who is still trying to figure out what helps.
The Autistic Brain
Temple Grandin and Richard Panek, 2013. Older but still useful as an accessible bridge between neuroscience and lived experience. Read alongside newer autistic-authored work rather than on its own.
Divergent Mind
Jenara Nerenberg, 2020. Draws together research on autism, ADHD, HSP, and synaesthesia, with a focus on women and non-binary people whose neurodivergence was missed. Heavy on interviews with researchers.
NeuroTribes
Steve Silberman, 2015. The history of how autism came to be understood — and misunderstood — in the twentieth century. Long, but worth it for the context it gives every other book on this list.
Wired to Feel
Sarah Bergenfield and Martha Sweezy, 2026. Reframes autism as a condition of sensory surplus rather than deficit. [VERIFY — released April 2026; we haven't reviewed it in full yet.]
Latest updates
Fresh research, policy changes, and support updates — translated into plain language within days, not years.
-
15 Apr 2025
US autism prevalence rises to 1 in 31 children
The CDC's Autism and Developmental Disabilities Monitoring Network found around 1 in 31 eight-year-olds in tracked US communities are now identified as autistic, up from 1 in 36. Researchers attribute most of the rise to better screening and broader access, especially in communities previously under-diagnosed. Read the CDC report.
-
20 Aug 2025
Australia announces NDIS "Thriving Kids" reform
Federal Minister Mark Butler announced that from 1 October 2026, children aged 8 and under with low-to-moderate support needs will move from the NDIS to a new state-delivered program called Thriving Kids, reaching full scale by January 2028. Advocacy groups have asked for a slower rollout and clearer detail on what families get in the transition. Department of Health overview.
-
30 Mar 2026
Large genetic study confirms autism genes are shared across ancestries
A Mount Sinai–led study in Nature Medicine analysed a large Latin American cohort and found 35 autism-linked genes overlapping strongly with those identified in earlier European-ancestry studies. The finding supports more equitable genetic research and diagnosis across populations. Mount Sinai announcement.
Get updates as they happen.
Get plain-language updates on autism research, diagnostic changes, and support pathways — the kind of information that normally takes years to reach families, delivered without the jargon. One email a fortnight, and you can unsubscribe any time.
You'll get a confirmation email shortly.